Clínica Ricardo Palma has sold a 50% stake to Quirónsalud
The shareholders of Administradora Clínica Ricardo Palma S.A. (Clínica Ricardo Palma) have sold 50% of their shares to Quirónsalud for an undisclosed consideration.
Clínica Ricardo Palma is a leading private clinic dedicated to providing health services in Peru.
Quirónsalud is the largest hospital operator in Spain with more than US$2 billion in revenues, 84 care centers (43 hospitals, 35 medical centers and 6 care homes), over 6,700 beds and 26,000 professionals. Quirónsalud offers patients comprehensive health care that encompasses all medical specialties.
Oaklins' team in Peru advised the seller in this transaction. After the acquisition of 50% of Clinica Ricardo Palma, Quirónsalud becomes a strategic partner.
Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more